India to New Zealand: Salicylic Export Trade Route
India has recorded 90 verified shipments of Salicylic exported to New Zealand, representing a combined trade value of $1.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $13.3K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 88% of total export value with 81 shipments worth $1.1M USD. On the buying side, HELLMANN WORLDWIDE LOGISTICS is the largest importer in New Zealand with $1.1M USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , TULSI MEDICAL & GENERAL STORES — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to New Zealand Salicylic corridor is one of India's established pharmaceutical export routes, with 90 shipments documented worth a combined $1.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's salicylic manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $13.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with salicylic's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 16.8%, placing it at rank #7 among India's top salicylic export destinations globally.
On the import side, key buyers of Indian salicylic in New Zealand include HELLMANN WORLDWIDE LOGISTICS, HELLMANN WORLDWIDE LOGISTICS , CONSIGNEE MASTER & OWNER OF SPIRIT. HELLMANN WORLDWIDE LOGISTICS is the single largest importer with 81 shipments valued at $1.1M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ1
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#7
- Annual growth+16.8%
- Demand growth+16.3%
- Regulatory ease74/100
Top 10 Indian Salicylic Exporters to New Zealand
Showing top 10 of 3 Indian suppliers exporting Salicylic to New Zealand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $13.0K per shipment | 81 | $1.1M | 88.1% |
| 2 | CIPLA LIMITED Avg $17.8K per shipment | 8 | $142.5K | 11.9% |
| 3 | TULSI MEDICAL & GENERAL STORES Avg $2 per shipment | 1 | $2 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting salicylic to New Zealand, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , TULSI MEDICAL & GENERAL STORES. CIPLA LIMITED is the dominant supplier with 81 shipments worth $1.1M USD, giving it a 88% market share.
Top 10 Salicylic Importers in New Zealand
Showing top 10 of 3 known buyers in New Zealand receiving Salicylic shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian salicylic in New Zealand include HELLMANN WORLDWIDE LOGISTICS, HELLMANN WORLDWIDE LOGISTICS , CONSIGNEE MASTER & OWNER OF SPIRIT. The largest importer is HELLMANN WORLDWIDE LOGISTICS, accounting for $1.1M USD across 81 shipments — representing 88% of all salicylic imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HELLMANN WORLDWIDE LOGISTICS | 81 | $1.1M | 88.1% |
| 2 | HELLMANN WORLDWIDE LOGISTICS | 8 | $142.5K | 11.9% |
| 3 | CONSIGNEE MASTER & OWNER OF SPIRIT | 1 | $2 | 0.0% |
Top 10 Salicylic Formulations Imported by New Zealand
Showing top 10 of 73 product formulations shipped on the India to New Zealand Salicylic route, ranked by trade value
New Zealand imports a wide range of salicylic formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- -CI02058 ( INV.QTY. 4080 PACK 33 — accounts for $24.0K USD across 1 shipments. There are 73 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- -CI02058 ( INV.QTY. 4080 PACK 33 | 1 | $24.0K | 2.0% |
| 2 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- -CI02058 ( INV.QTY. 4061 PACK 33 | 1 | $23.9K | 2.0% |
| 3 | ETHICS ASPIRIN ENTERIC COATED 100MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 INV.QTY.4083 PACK 33X30'S= | 3 | $23.8K | 2.0% |
| 4 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 (INV.QTY 4062 PACK 33X30S=4021380 N | 1 | $23.8K | 2.0% |
| 5 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- -CI02058 ( INV.QTY. 4050 PACK 33 | 1 | $23.8K | 2.0% |
| 6 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 (INV.QTY 4060 PACK 33X30S=4019400 N | 1 | $23.8K | 2.0% |
| 7 | ETHICS ASPIRIN ENTERIC COATED 100MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 INV.QTY.4073 PACK 33X30'S= | 3 | $23.8K | 2.0% |
| 8 | ETHICS ASPIRIN ENTERIC COATED 100MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 INV.QTY.4072 PACK 33X30'S= | 3 | $23.8K | 2.0% |
| 9 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET ACETYL SALICYLIC ACID 100 MG CI02058 INV QTY 4128 PACK 33X30S 4086720 N | 1 | $23.8K | 2.0% |
| 10 | ETHICS ASPIRIN ENTERIC COATED 100 MG TABLET (ACETYL SALICYLIC ACID 100 MG)- CI02058 (INV.QTY.4056 PACK 33X30S=4015440 N | 1 | $23.8K | 2.0% |
Showing top 10 of 73 Salicylic formulations imported by New Zealand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 27 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's salicylic exports to New Zealand are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 81 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , TULSI MEDICAL & GENERAL STORES — together account for 100% of total trade value on this route. The average shipment value of $13.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ethics aspirin enteric coated 100 mg tablet (acetyl salicylic acid 100 mg)- -ci02058 ( inv.qty. 4061 pack 33 and ethics aspirin enteric coated 100mg tablet (acetyl salicylic acid 100 mg)- ci02058 inv.qty.4083 pack 33x30's=, suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, HELLMANN WORLDWIDE LOGISTICS is the largest importer with 81 shipments worth $1.1M USD — representing 88% of all salicylic imports from India on this route.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $13.3K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~34 days
- Annual Growth
- +16.8%
Other Salicylic Routes
Unlock the Full India to New Zealand Salicylic Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 90 shipments on this route.
Frequently Asked Questions — India to New Zealand Salicylic Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Salicylic to New Zealand?
The leading Indian exporters of Salicylic to New Zealand are CIPLA LIMITED, CIPLA LIMITED , TULSI MEDICAL & GENERAL STORES. CIPLA LIMITED holds the largest market share at approximately 88% of total trade value on this route.
Q What is the total value of Salicylic exports from India to New Zealand?
India exports Salicylic to New Zealand worth approximately $1.2M USD across 90 recorded shipments. The average value per shipment is $13.3K USD.
Q Which ports does India use to ship Salicylic to New Zealand?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 27 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to New Zealand for Salicylic?
The average transit time for Salicylic shipments from India to New Zealand is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to New Zealand Salicylic trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.8% with demand growth tracking at 16.3%. The route is ranked #7 among India's top Salicylic export destinations globally.
Q How many suppliers are active on the India to New Zealand Salicylic route?
There are currently 3 active Indian suppliers exporting Salicylic to New Zealand. The market is moderately concentrated with CIPLA LIMITED accounting for 88% of total shipment value.
Q Who are the main importers of Salicylic from India in New Zealand?
The leading importers of Indian Salicylic in New Zealand include HELLMANN WORLDWIDE LOGISTICS, HELLMANN WORLDWIDE LOGISTICS , CONSIGNEE MASTER & OWNER OF SPIRIT. HELLMANN WORLDWIDE LOGISTICS is the largest buyer with 81 shipments worth $1.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Salicylic.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 90 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
90 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists